01Premium packaging
Every vial rests in a high-quality box with a precision foam inlay – protected, dust-free and beautifully presented.
Triple hormone receptor agonist
Next-generation peptide that targets GLP-1, GIP and glucagon receptors to support weight management, metabolism and body composition.
Weight management and appetite control.
Retatrutide belongs to a new generation of peptides and is frequently mentioned in connection with weight management and body composition.
Triple agonist of the GLP-1, GIP and glucagon receptors. Reduces appetite, increases satiety, improves insulin sensitivity, boosts energy expenditure and supports fat loss while preserving muscle mass.
Lyophilised powder for reconstitution with BAC water. Maximum flexibility in concentration, lowest price per unit.
Pre-filled and ready to use. Precise dosing without preparation – ideal when handling and time savings matter most.
Retatrutide belongs to a new generation of peptides and is frequently mentioned in connection with weight management and body composition.
The vial is a lyophilised powder that is reconstituted with BAC water before use. The pen comes ready prepared and allows precise, simple dosing without extra preparation – for this the price is €40 above the identical vial.
2 – 8 °C (gekühlt lagern) · Shelf life: 24 Monate.
Yes. On request we provide a current COA with HPLC analysis for every batch.
20 mg · 30 mg – each available as a vial or as a prefilled pen.
Tesamorelin · AOD9604 · HGH
Use the enquiry button to send us the product and quantity. You will receive a binding quote including shipping options shortly.
We treat every shipment like a precision product: premium packaging, an unbroken cold chain and discreet delivery.
01Every vial rests in a high-quality box with a precision foam inlay – protected, dust-free and beautifully presented.
02A neutral outer carton with no logo or product reference – sealed, sturdy and sent with tracking.
Send us the product and quantity – you will receive a binding quote including shipping options shortly.

